Schweizer, M. T., Huang, P., Kattan, M. W., Kibel, A. S., de Wit, R., Sternberg, C. N., . . . Eisenberger, M. A. (2013). Adjuvant Leuprolide With or Without Docetaxel in Patients With High-Risk Prostate Cancer After Radical Prostatectomy (TAX-3501): Important Lessons for Future Trials.

Schweizer, Michael T., Peng Huang, Michael W. Kattan, Adam S. Kibel, Ronald de Wit, Cora N. Sternberg, Jonathan I. Epstein, and Mario A. Eisenberger. Adjuvant Leuprolide With or Without Docetaxel in Patients With High-Risk Prostate Cancer After Radical Prostatectomy (TAX-3501): Important Lessons for Future Trials. 2013.

Schweizer, Michael T., et al. Adjuvant Leuprolide With or Without Docetaxel in Patients With High-Risk Prostate Cancer After Radical Prostatectomy (TAX-3501): Important Lessons for Future Trials. 2013.